Lv3
300 积分 2025-06-20 加入
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study
5天前
已完结
Switching from baricitinib to dupilumab as an advanced‐line treatment in pediatric patients with atopic dermatitis: a retrospective cohort study
5天前
已完结
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
5天前
已完结
Biologic and Small Molecule Therapy Switch in Atopic Dermatitis Patients with Dupilumab-Associated Ocular Surface Disease: A Systematic Review
5天前
已完结
Management of inadequate response and adverse effects to dupilumab in atopic dermatitis
5天前
已完结
Improvement of dupilumab-associated conjunctivitis after switching to upadacitinib in a patient with atopic dermatitis
5天前
已完结
Evolution of dupilumab-associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO-ADOC study)
5天前
已完结
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study
5天前
已完结
Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects
5天前
已完结
Letter: Real-World Japanese Study of the Effectiveness and Safety of Switching From Dupilumab to Lebrikizumab in Patients with Moderate to Severe Atopic Dermatitis
5天前
已完结
皖公网安备34019202002308
